More articles from Editorial

Open Access
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China
Jianbin Li and Zefei Jiang

Cancer Biology & Medicine October 2024, 21 (10) 838-843; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0374
Open Access
Inflammatory signaling in targeted therapy resistance: focus on EGFR-targeted treatment
Zhihong Luo and Ke Gong

Cancer Biology & Medicine October 2024, 21 (10) 831-837; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0327
Open Access
Evolving molecular subtyping of breast cancer advances precision treatment
Rui Shan, Lei-Jie Dai, Zhi-Ming Shao and Yi-Zhou Jiang

Cancer Biology & Medicine September 2024, 21 (9) 731-739; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0222
Open Access
SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens
Yawen Weng, Jing Xue and Ningning Niu

Cancer Biology & Medicine September 2024, 21 (9) 725-730; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0201
Open Access
Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu and Liu Cao

Cancer Biology & Medicine July 2024, 21 (7) 541-546; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0157
Open Access
Epigenetic regulators as the foundation for molecular classification of colorectal cancer
Zhenyu Liu, Xin Zhou and Fuchou Tang

Cancer Biology & Medicine July 2024, 21 (7) 547-552; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0176
Open Access
Roles of cancer-associated fibroblast functional heterogeneity in shaping the lymphatic metastatic landscape: new insights and therapeutic strategies
Hanhao Zheng, Daiyin Liu, Zhicong Liu, Mingjie An, Yuming Luo, Changhao Chen and Tianxin Lin

Cancer Biology & Medicine June 2024, 21 (6) 445-450; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0138
Open Access
Hodgkin’s lymphoma: 2023 update on treatment
Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang and Huilai Zhang

Cancer Biology & Medicine April 2024, 21 (4) 269-273; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0427
Open Access
Peptide drugs: a new direction in cancer immunotherapy
Xinghua Sui, Xiaoshuang Niu, Xiuman Zhou and Yanfeng Gao

Cancer Biology & Medicine March 2024, 21 (3) 198-203; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0297
Open Access
Reducing the global cancer burden with gastrointestinal screening: China’s 30 years practice
Lei Yang, Li Feng, Yong Zhu, Ning Wang, Xinpu Lu, Fanghui Gu, Xiaotian Zhang and Jiafu Ji

Cancer Biology & Medicine March 2024, 21 (3) 204-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0516

Main menu

User menu

Search

More articles from Editorial

Pages

Navigate

More Information

For Authors

Journal Services